COLLAGEN MELANOCYTE COMPLEX, PREPARATION METHOD AND USE THEREOF

Abstract

The present disclosure provides a preparation method of a collagen melanocyte complex and use of the collagen melanocyte complex. The collagen material is a scaffold material with good biocompatibility, mechanical properties, and degradation performance, which is prepared based on tissue engineering technology. The present disclosure relates to the preparation of a collagen scaffold and the construction of a collagen melanocyte complex. Melanocytes on the scaffold material have higher cell activity and better melanin secretion ability. The collagen melanocyte complex avoids the loss of cell suspension during cell transplantation and provides a good three-dimensional growth environment for cells. The collagen melanocyte complex prepared by the present disclosure can be used in patients with vitiligo or patients with pigment deficiency and epidermal damage.

Claims

1. A preparation method for a collagen melanocyte complex, comprising preparing a cross-linked collagen sponge scaffold material firstly, inoculating melanocytes on the cross-linked collagen sponge scaffold material and then culturing in vitro.

2. The preparation method according to claim 1, wherein a method for preparing the cross-linked collagen sponge scaffold material comprises the following steps: adding a collagen with appropriate size to a reaction solvent, adding a cross-linking agent to the reaction solvent, and magnetically stirring; after completion of the reaction, performing washing, freeze-drying, and sterilizing.

3. The preparation method according to claim 1, wherein the collagen is aquatic animal collagen or mammalian collagen; the collagen has a thickness of 0.5-10 mm sponge, which is cut into a shape not larger than a petri dish; the reaction solvent is ethanol or water phase, preferably 90% ethanol or PBS solution with pH=5.5; the cross-linking agent is EDC and NHS, and a molar ratio of EDC:NHS is in a range of 1:1 to 1:4; a time of the magnetic stirring is in a range of 2-72 h, preferably in a range of 24-48 h; a reaction temperature is in a range of 4-30° C., preferably in a range of 20-25° C.; and the washing condition includes soaking in phosphate buffer for 1-2 h, and washing with purified water for 1-24 h.

4. The preparation method according to claim 1, wherein inoculating melanocytes on the cross-linked collagen sponge scaffold material and culturing in vitro comprise the following steps: pre-plating the collagen sponge scaffold material onto a cell culture plate, inoculating 100 μl-1000 μl melanocytes to the collagen sponge scaffold material at a density of 2*10.sup.4 to 2*10.sup.7 cells/ml, and then culturing in a cell incubator under the condition of 37° C., 5% CO.sub.2, and saturated humidity; after the collagen scaffold inoculated with melanocytes is cultured for 30 min-2 h, supplementing with cells medium 1 ml-10 ml, and continuing culturing in a cell incubator under the condition of 37° C., 5% CO.sub.2, and saturated humidity; replacing the cell medium of the culture plate covered with the collagen sponge scaffold material with a new cell medium every two days, a culture time being in a range of 1 to 25 days, and obtaining the melanocyte-collagen complex.

5. The preparation method according to claim 1, wherein the melanocytes are human melanocytes; and the human melanocytes are melanocytes extracted from autologous or allogeneic tissues.

6. The preparation method according to claim 1, wherein skin color is adjusted by adjusting the density, number or culture time of the inoculated cells.

7. A collagen melanocyte complex, wherein the collagen melanocyte complex is a complex of a collagen scaffold and a melanocyte prepared by the method of claim 1.

8. A method for treating pigment deficiency and epidermal damage, comprising administering to a subject in need thereof a therapeutically effective amount of the collagen melanocyte complex of claim 7.

9. The method according to claim 8, wherein when preparing the collagen melanocyte complex, the skin color is adjusted by adjusting the density, number or culture time of the inoculated cells.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0018] The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.

[0019] FIG. 1 shows microscopic observation of morphology of melanocytes cultured with cross-linked collagen scaffold extract.

[0020] FIG. 2 is a picture of laser confocal microscope observation of the collagen melanocyte complex of Example 4 on day 15.

[0021] FIG. 3 shows the pictures of visual observation of melanocyte proliferation and melanin secretion; in which a-1 is the picture of blank group took after culturing in vitro for 6 days, a-2 is the picture of blank group took after culturing in vitro for 15 days, b-1 is the picture of uncross-linked group of Example 5 took after culturing in vitro for 6 days, b-2 is the picture of uncross-linked group of Example 5 took after culturing in vitro for 15 days, c-1 is the picture of cross-linked group of Example 1 took after culturing in vitro for 6 days, c-2 is the picture of cross-linked group of Example 1 took after culturing in vitro for 11 days, d-1 is the picture of cross-linked group of Example 2 took after culturing in vitro for 6 days, d-2 is the picture of cross-linked group of Example 2 took after culturing in vitro for 15 days, e-1 is the picture of cross-linked group of Example 3 took after culturing in vitro for 6 days, e-2 is the picture of cross-linked group of Example 3 took after culturing in vitro for 15 days, f-1 is the picture of cross-linked group of Example 4 took after culturing in vitro for 15 days, f-2 is the picture of cross-linked group of Example 4 took after culturing in vitro for 24 days.

DETAILED DESCRIPTION OF THE EMBODIMENTS

[0022] The present disclosure is further described with the following specific examples.

Example 1: Preparation Method of Cross-Linked Collagen Melanocyte Complex

[0023] 1 g collagen sponge was cut into 1 cm*1 cm squares, put into a 1000 mL beaker. 500 mL of 90% ethanol was added, stirred magnetically at room temperature. 9.6 g EDC and 11.5 g NHS were added, and then reacted for 48 h. After the reaction, the cross-linked collagen sponge was soaked with a 0.1 mol/L phosphate buffer solution, stirred magnetically for 1 h, washed with purified water, freeze-dried and sterilized by irradiation.

[0024] The sterile collagen sponge was cut into materials of uniform size: the upper surface being 1 cm*1 cm square, and the thickness being 5 mm. The cutting scaffold material was then pre-plated onto a cell culture plate. 200 μl melanocytes were inoculated on a collagen scaffold at a density of 1*10.sup.5 cells/ml, and cultured in a cell incubator at 37° C., 5% CO.sub.2, and saturated humidity. After 2 hours of culture, 1 ml cell culture medium (without penicillin streptomycin) was added to the culture plate plated with the scaffold material, and the cells were cultured in the cell incubator at 37° C., 5% CO.sub.2, and saturated humidity. The cell medium was changed every two days and the culture time was 11 days.

Example 2: Preparation Method of Cross-Linked Collagen Melanocyte Complex

[0025] 1 g collagen sponge was cut into 1 cm*1 cm squares, put into a 1000 mL beaker. 500 mL of 90% ethanol was added, stirred magnetically at room temperature. 9.6 g EDC and 11.5 g NHS were added, and then reacted for 48 h. After the reaction, the cross-linked collagen sponge was soaked with a 0.1 mol/L phosphate buffer solution, stirred magnetically for 1 h, washed with purified water, freeze-dried and sterilized by irradiation.

[0026] The sterile collagen sponge was cut into materials of uniform size: the upper surface being 1 cm*1 cm square, and the thickness being 5 mm. The cutting scaffold material was then pre-plated onto a cell culture plate. 400 μl melanocytes were inoculated on a collagen scaffold at a density of 1*10.sup.5 cells/ml, and cultured in a cell incubator at 37° C., 5% CO.sub.2, and saturated humidity. After 2 hours of culture, 1 ml cell culture medium (without penicillin streptomycin) was added to a collagen plate-covered culture plate, and the cells were cultured in the cell incubator at 37° C., 5% CO.sub.2, and saturated humidity. The cell medium was changed every two days and the culture time was 16 days.

Example 3: Preparation Method of Cross-Linked Collagen Melanocyte Complex

[0027] 1.5 g collagen sponge wan cut into 1 cm*1 cm squares, put into a 1000 mL beaker, 500 mL of 90% ethanol was added, stirred magnetically at room temperature, 9.6 g EDC and 11.5 g NHS were added, and then reacted for 48 h. After the reaction, the cross-linked collagen sponge was soaked with a 0.1 mol/L phosphate buffer solution, stirred magnetically for 1 h, washed with purified water, freeze-dried and sterilized by irradiation.

[0028] The sterile collagen sponge was cut into materials of uniform size: the upper surface being 1 cm*1 cm square, and the thickness being 5 mm. The cutting scaffold material was then pre-plated onto a cell culture plate. 400 μl melanocytes were inoculated on a collagen scaffold at a density of 1*10.sup.5 cells/ml, and cultured in a cell incubator at 37° C., 5% CO.sub.2, and saturated humidity. After 2 hours of culture, 1 ml cell culture medium (without penicillin streptomycin) was added to the culture plate plated with the scaffold material, and the cells were cultured in the cell incubator at 37° C., 5% CO.sub.2, and saturated humidity. The cell medium was changed every two days and the culture time was 16 days.

Example 4: Preparation Method of Cross-Linked Collagen Melanocyte Complex

[0029] 0.5 g collagen sponge was cut into 1 cm*1 cm squares, put into a 1000 mL beaker, 500 mL of 90% ethanol was added, stirred magnetically at room temperature, 7.68 g EDC and 4.6 g NHS were added, and then reacted for 48 h. After the reaction, the cross-linked collagen sponge was soaked with a 0.1 mol/L phosphate buffer solution, stirred magnetically for 1 h, washed with purified water, freeze-dried and sterilized by irradiation.

[0030] The sterile collagen sponge was cut into materials of uniform size: the upper surface being 1 cm*1 cm square, and the thickness being 5 mm. The cutting scaffold material was then pre-plated onto a cell culture plate. 200 μl melanocytes were inoculated on a collagen scaffold at a density of 2.5*10.sup.5 cells/ml, and cultured in a cell incubator at 37° C., 5% CO.sub.2, and saturated humidity. After 2 hours of culture, 1 ml cell culture medium (without penicillin streptomycin) was added to the culture plate plated with the scaffold material, and the cells were cultured in the cell incubator at 37° C., 5% CO.sub.2, and saturated humidity. The cell medium was changed every two days and the culture time was 24 days.

Example 5: Preparation Method of Uncross-Linked Collagen Melanocyte Complex

[0031] The treated bovine Achilles tendon was dissolved with dilute acid, digested with pepsin for 72-90 hours, NaCl was added to a concentration of 2.5˜2.6 mol.Math.L.sup.−1, filtered and salt out for more than 24 hours, PBS solution dialyzed, freeze-dried into a sponge shape, and radiation sterilization after cut.

[0032] The sterile uncross-linked collagen sponge was cut into materials of uniform size: the upper surface being 1 cm*1 cm square, and the thickness being 5 mm. The cutting scaffold material was then pre-plated onto a cell culture plate. 200p1 melanocytes were inoculated on a collagen scaffold at a density of 2.5*10.sup.5 cells/ml, and cultured in a cell incubator at 37° C., 5% CO.sub.2, and saturated humidity. After 2 hours of culture, 1 ml cell medium (without penicillin streptomycin) was added to the culture plate plated with the scaffold material, and the cells were cultured in the cell incubator at 37° C., 5% CO.sub.2, and saturated humidity. The cell medium was changed every two days and the culture time was 15 days.

[0033] Result Analysis:

[0034] 1) Analysis of Mechanical Properties of Cross-Linked Collagen Scaffold Materials

[0035] Mechanical property testing method: both ends of the scaffold material are held with a clip and pulled until the material breaks. Test conditions: the tensile speed is 300 mm/min, the humidity is 57%, the maximum peeling force is measured with a tensile machine and is the average of three measurements. The maximum peeling forces of the cross-linked collagen scaffold materials prepared in Examples 1, 2, 3, and 4 are all above 2.5N. This indicates that the cross-linked collagen scaffold material prepared by this method has good mechanical properties, and ensures that the collagen scaffold material can be freely sheared without breaking during the process of using according to requirements. After the culture in vitro of the cross-linked collagen melanocyte complex in Examples 1, 2, 3, and 4 for 11-24 days, no significant degradation or fragmentation of the scaffold material is found, and the material remained intact like starting to inoculate melanocytes, and the largest peeling force is still above 2.5N. At the same time, the collagen melanocyte complex cultured in vitro can be successfully transferred to the affected area without breaking.

[0036] 2) Cytotoxicity Analysis of Cross-Linked Collagen Scaffold Material

[0037] The CCK-8 cytotoxicity test of the cross-linked collagen scaffolds prepared in Examples 1, 2, 3, and 4 shows that the survival rate of the cell cultured in scaffold extracts prepared by this method is above 97%. The morphology of the cells is normal, the cells are slender, the number of dendrites is in a range of 2 to 5 or more, and different dendrites have different lengths (as shown in FIG. 1), which is not significantly different from that of the blank group. It shows that the collagen material prepared by this method has good biocompatibility and can be applied in tissue engineering and biomedical fields.

[0038] 3) Cell Proliferation Analysis

[0039] The cross-linked collagen melanocyte complex in Example 4 was cultured for 15 days. After fluorescence (green) staining of live cells, laser confocal observation reveals that the melanocytes are proliferated a lot in the cross-linked collagen scaffold. There are more living melanocytes on the surface of the scaffold material and inside the three-dimensional structure. This shows that the three-dimensional structure of the cross-linked collagen scaffold material prepared by this method is beneficial to the growth of melanocytes.

[0040] The results of the cell culture in vitro of Examples 1, 2, 3, and 4 are shown in FIG. 3. By observing FIG. 3, it is found that the melanocytes did not proliferate significantly in the uncross-linked group in 6 days; the melanocytes proliferated significantly in 15 days, and the material also became significantly darker due to melanin secretion. However, the thickness of the material had been degraded from 5 mm to approximately 0.5 mm, which was a thin layer. In the cross-linked group, the melanocyte proliferated significantly and the melanin secreted significantly. A large amount of melanin secreted in 24 days, and the scaffold material had changed from light black to dark black. This phenomenon indicates that the melanocytes have higher cell activity on the scaffold material. The scaffold material also provides a good three-dimensional growth environment for the cells, which is conducive to the proliferation of the cells in three-dimensional space. The amounts of melanin secreted by the collagen melanocytes obtained at different concentrations or different culture conditions are different, and it is expected that different skin colors can be adjusted accordingly.

[0041] The above description is only part of the embodiments of the present disclosure, and the protection scope of the present disclosure is not limited to the above embodiments, and does not represent all technical schemes under the concept of the present disclosure. It should be pointed out that, for those skilled in the art, any improvement and retouching should be considered as the scope of protection of the present disclosure if it is inspired by the concept of the patent and specific implementation cases without departing from the principle of the present disclosure.